D065840Concepts & IdeasE05.318.740.600.800.582N05.715.350.200.675N05.715.360.750.625.700.570N06.850.490.625.625N06.850.520.830.600.800.58213170.993708Protective FactorsFaculty Rankprns:fullNamefull nameprns:hasAuthorListauthor listprns:hasFacultyRankhas faculty rankprns:hasNetworkhas networkprns:hasPublicationVenuepublished inprns:informationResourceReferenceinformation resource referenceprns:isPrimaryPositionis primary positionprns:latitudelatitudeprns:longitudelongitudeprns:mainImagephotoprns:maxWeightmaximum weightprns:medlineTAjournal title abbreviationprns:meshDescriptorUIMeSH DescriptorUIprns:meshSemanticGroupNameMeSH semantic group nameprns:meshTreeNumberMeSH tree numberprns:minWeightminimum weightprns:numberOfAuthorsnumber of authorsprns:numberOfConnectionsnumber of connectionsprns:numberOfPublicationsnumber of publicationsprns:personIdPerson IDprns:personInPrimaryPositionperson in primary positionprns:positionInDepartmentposition in departmentprns:positionInDivisionposition in divisionprns:predicateNodepredicate nodeprns:publicationDatepublication dateprns:sortOrdersort orderprns:uniquenessWeightuniqueness weightprns:yearyearAcademic ArticleArticleDocumentbibo:pmidPubMed IdentifierDepartmentDivisionvivo:hrJobTitleHR job titleInformation Resourcevivo:orcidIdORCID idPositionvivo:positionInOrganizationposition in organizationvivo:preferredTitlepreferred titlevivo:researchAreaOfresearch area ofvivo:subjectAreaForsubject area forrdf:predicatepredicaterdf:typetyperdfs:labellabelConceptAgentfoaf:firstNamefirst namefoaf:lastNamelast nameOrganizationPerson30586766Lloyd-Jones DM, Braun LT, Ndumele CE, Smith SC, Sperling LS, Virani SS, Blumenthal RSCirculationUse of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019 06 18; 139(25):e1162-e1177.Circulation2018-11-10T00:00:002018Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology.0.1858940.032931913research area of0.228190.1322615subject area fortrue1ProfessorProfessorRobertMcCarthyRobert McCarthy350081McCarthy, Robert0000-0002-0966-5311ProfessorAnesthesiologyPediatricsAlokaPatelAloka Lahoti Patel41.87464250000000-87.66915400000000349106Patel, AlokaProfessorJeanSilvestriJean Silvestri349664Silvestri, JeanProfessorAnnabelleVolgmanAnnabelle Volgman349709Volgman, AnnabelleProfessor31960742Brown SA, Okwuosa TM, Barac A, Volgman ASJournal of the American Heart AssociationThe Role of Angiotensin-Converting Enzyme Inhibitors and ?-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients. J Am Heart Assoc. 2020 01 21; 9(2):e015327.J Am Heart Assoc2020-01-21T00:00:002020The Role of Angiotensin-Converting Enzyme Inhibitors and ?-Blockers in Primary Prevention of Cardiac Dysfunction in Breast Cancer Patients.4Professor31996451Holland TM, Agarwal P, Wang Y, Leurgans SE, Bennett DA, Booth SL, Morris MCNeurologyDietary flavonols and risk of Alzheimer dementia. Neurology. 2020 04 21; 94(16):e1749-e1756.Neurology2020-01-29T00:00:002020Dietary flavonols and risk of Alzheimer dementia.Neurological SciencesRush University, Rush Medical CollegeDavidBennettDavid A. Bennett41.87328300000000-87.66936330000000349004Bennett, DavidProfessortrue1ProfessorProfessor34371083Al Rifai M, Blumenthal RS, Stone NJ, Schofield RS, Orringer CE, Michos ED, Heidenreich PA, Braun L, Birtcher KK, Smith SC, Nambi V, Grundy S, Virani SSProgress in cardiovascular diseasesDepartment of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context. Prog Cardiovasc Dis. 2021 Sep-Oct; 68:2-6.Prog Cardiovasc Dis2021-08-08T00:00:002021Department of Veterans Affairs (VA) and U.S. Department of Defense (DoD) guidelines for management of dyslipidemia and cardiovascular disease risk reduction: Putting evidence in context.true1ProfessorProfessortrue1ProfessorProfessortrue1ProfessorProfessorInternal Medicine, Division of Cardiology36380716Molad J, Hallevi H, Seyman E, Rotschild O, Bornstein NM, Tene O, Giladi N, Hausdorff JM, Mirelman A, Ben Assayag EEuropean journal of neurologyCCR5-?32 polymorphism-a possible protective factor from gait impairment amongst post-stroke patients. Eur J Neurol. 2023 03; 30(3):692-701.Eur J Neurol2022-12-03T00:00:002022CCR5-?32 polymorphism-a possible protective factor from gait impairment amongst post-stroke patients.